Skip to main content
AMSKY Technology Co.,Ltd. logo

AMSKY Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300521 ISIN · CNE1000027W7 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,377 across all filing types
Latest filing 2022-08-24 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300521

About AMSKY Technology Co.,Ltd.

https://www.amsky.com

AMSKY Technology Co., Ltd. specializes in the research, development, and manufacturing of industrial precision printing equipment. The company’s core product portfolio includes Computer-to-Plate (CTP) systems for the offset and flexographic printing sectors, utilizing advanced thermal and UV laser imaging technologies. Beyond traditional prepress solutions, AMSKY has expanded into industrial inkjet printing and additive manufacturing, specifically developing high-speed sand 3D printers for foundry applications. The company leverages proprietary expertise in multi-channel laser control, piezoelectric inkjet drive technology, and high-precision motion systems to provide digital transformation solutions for the global printing and manufacturing industries. Its products serve diverse markets, including commercial printing, packaging, and industrial casting.

Recent filings

Filing Released Lang Actions
关于本次交易不构成《上市公司重大资产重组管理办法》第十三条规定的重组上市情形的说明
Regulatory Filings Classification · 95% confidence The document is a formal statement from the board of directors of 爱司凯科技股份有限公司 regarding a transaction involving the purchase of a 99.97% equity stake in another company. It specifically clarifies that this transaction does not constitute a major asset restructuring under the relevant regulatory rules (《上市公司重大资产重组管理办法》第十三条). The document is short (433 characters) and serves as an official announcement or explanation about the nature of the transaction rather than a detailed report or financial statement. It does not contain financial data or detailed analysis but is a regulatory announcement clarifying the status of the transaction. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such regulatory announcements that do not fit other specific categories.
2022-08-24 Chinese
关于所提供信息真实性、准确性和完整性的声明承诺函(三)
Regulatory Filings Classification · 95% confidence The document is a statement of truthfulness, accuracy, and completeness of information provided in relation to a transaction involving the purchase of equity and fundraising. It contains multiple commitments and legal assurances from various parties involved in the transaction. There are no financial statements, no audit opinions, no earnings data, no meeting materials, or voting results. The document is a legal commitment letter related to a transaction, not a report or announcement of financial results or governance changes. It does not fit into categories like Annual Report, Audit Report, Earnings Release, or Management Reports. It is also not a proxy solicitation or voting result announcement. The document is best classified as a Regulatory Filing (RNS) because it is a compliance-related legal statement associated with a transaction but does not itself constitute a financial or governance report.
2022-08-24 Chinese
关于本次交易相关主体不存在《上市公司监管指引第7号——上市公司重大资产重组相关股票异常交易监管》第十三条不得参与任何上市公司的重大资产重组情形的说明
Regulatory Filings Classification · 95% confidence The document is a statement from the board of directors of a company regarding compliance with regulatory guidelines related to a major asset restructuring transaction. It specifically addresses the absence of any involvement in prohibited activities under a regulatory guideline concerning major asset restructurings and abnormal stock trading. The document does not contain financial data, detailed transaction terms, or a full report but rather a compliance explanation related to a transaction. This fits best under Regulatory Filings (RNS) as it is a regulatory compliance announcement rather than a full M&A filing or capital update.
2022-08-24 Chinese
董事会关于公司股票价格波动达到《深圳证券交易所上市公司自律监管指引第8号—重大资产重组》第十三条第(七)款标准的说明
Regulatory Filings Classification · 95% confidence The document is a formal announcement from the board of directors of 爱司凯科技股份有限公司 regarding the stock price volatility reaching a threshold defined by the Shenzhen Stock Exchange's self-regulatory guidelines for major asset restructurings. It provides detailed stock price data, comparisons with relevant indices, and risk warnings related to potential regulatory investigations. The document does not contain financial statements or detailed financial performance data but serves as a regulatory disclosure about stock price movement and associated risks. It is not a full report like an Annual Report or Interim Report, nor is it a voting result or management change announcement. It fits best as a Regulatory Filing (RNS) because it is a compliance-related disclosure about stock price volatility and risk warnings under regulatory guidelines.
2022-08-24 Chinese
关于暂不召开股东大会的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from the board of directors of 爱司凯科技股份有限公司 regarding the decision to temporarily not convene a shareholders' meeting (股东大会) to approve a transaction involving the issuance of shares and cash payment to acquire a controlling stake in another company. It mentions that the audit and evaluation work is not yet complete and that the meeting will be scheduled later. This is a regulatory announcement about the status of a shareholder meeting related to a capital transaction, not the transaction itself or a full report. The document is short (655 characters) and serves as a formal notice about the postponement of a shareholders' meeting. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-08-24 Chinese
第四届董事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the fourth meeting of the fourth board of directors of 爱司凯科技股份有限公司 (Aiskay Technology Co., Ltd.) held on August 24, 2022. It discusses the company's plan to issue shares and pay cash to purchase assets and raise supporting funds, including detailed terms of the transaction, pricing, lock-up periods, performance commitments, and authorization for the board to handle related matters. The document references compliance with relevant laws and regulations, including the Securities Law, Company Law, and rules on major asset restructuring. It is a formal board meeting resolution announcement related to a major asset acquisition and capital raising transaction. It does not contain financial statements or detailed financial analysis but rather the board's decisions and approvals regarding the transaction. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management, including major transaction approvals.
2022-08-24 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.